Media Release CASTEL SAN PIETRO, 28 May 2020 – Medacta announced today the first surgery utilizing its recently FDA-cleared Mecta-C Stand Alone platform for anterior cervical discectomy and fusion procedures (ACDF). After obtaining the FDA clearance in March, Mecta-C Stand Alone has also obtained CE marking and approval from Australia’s Therapeutic Goods Administration (TGA). The first surgery …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone